| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | Reardon Tighe | Acting Chief Financial Officer | Nov 13, 2023 | Buy | $5.87 | 849,854 | 4,988,643 | 849,854 | Nov 15, 2023, 04:48 PM | |
| JANX | Janux Therapeutics, Inc. | Reardon Tighe | Acting Chief Financial Officer | Jun 15, 2021 | Buy | $17.00 | 629,411 | 10,699,987 | 4,479,492 | Jun 16, 2021, 06:11 PM | |
| THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financial Officer | Jan 23, 2020 | Option Exercise | $68.00 | 43,688 | 2,970,784 | 0 | Jan 24, 2020, 06:36 PM | |
| THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financial Officer | Jan 23, 2020 | Option Exercise | $68.00 | 1,682,086 | 114,381,848 | 0 | Jan 24, 2020, 06:36 PM | |
| THOR | Synthorx, Inc. | Reardon Tighe | Acting Chief Financial Officer | Dec 11, 2018 | Buy | $11.00 | 545,455 | 6,000,005 | 1,682,086 | Dec 13, 2018, 06:36 PM |
Menu